Browse the full record of transactions filed by KYUNG NAM-WORTMAN, Vice-Présidente Exécutive, Directrice des Ressources Humaines. Insider active across 1 companies, notably CELLECTIS. Cumulatively, 2 filings have been logged. The latest transaction was filed on 24 May 2025 — ACQUISITION OF FREE SHARES. Regulator: AMF. All data is accessible without signup.
2 of 2 declarations
Kyung Nam-Wortman serves as Executive Vice President, Chief Human Resources Officer at Cellectis, a role she has held since November 2020. She is also a member of the company’s executive committee and is based in New York. In this position, she is responsible for advancing Cellectis’ roadmap through the recruitment and retention of top talent. Her remit also includes strengthening the company’s dynamic and inclusive culture and optimizing the human resources function to support the organization’s growth in biotechnology. Before joining Cellectis, she held senior leadership roles at Achillion, which was acquired by Alexion in January 2020. There, she served as Senior Vice President, Head of Human Resources, Head of Information Technology, Facilities and Internal Communications. That role gave her broad responsibility over both strategic and operational aspects of key corporate support functions, reflecting strong leadership across complex, multi-functional environments. Prior to Achillion, Kyung Nam-Wortman was Vice President and Head of Global Talent and Organization Capability at Zoetis. In that capacity, she supported the spin-off of Pfizer’s animal health business through its IPO and helped build Zoetis’ global talent management function to support the company’s worldwide expansion. She also held several human resources leadership positions at Pfizer with regional and global scope across business units, divisions, and functions. Earlier in her career, she spent 14 years in consulting, focusing on strategic and organizational change management at Delta Consulting Group and IBM. She earned a bachelor’s degree in marketing from New York University Stern School of Business and an MS in Human Resources Management / Organizational Development from The New School of Social Research. Her background combines human capital strategy, change leadership, and international biopharma experience, making her a seasoned executive in people and organization leadership.